Botanical species · safety record

Erysimum diffusum

The EFSA Compendium of Botanicals holds 4 constituent measurements for Erysimum diffusum. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Erysimum diffusum Ehrh.

4Constituent measurements
0Safety records
4Cited sources
0Licensed products (Canada)

Regulatory presence

No Health Canada licensed natural health product in the snapshot names this species as a medicinal ingredient under this exact binomial. Absence here means absence from this one register under this one name, not absence from trade, and not a safety verdict.

What the records describe

Constituents measured

  • Cardenolides1
  • Cardiac glycosides1
  • Erysimoside1
  • Strophantidin1

Plant parts

  • Seed4

Preparations

  • Solvent extraction3

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
Cardiac glycosidesSeedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)Resolve DOI
CardenolidesSeedSolvent extractionStandard Chromatographic tests (paper- thin layer- and column chromatography)No resolvable identifier
ErysimosideSeedUnspecifiedNo resolvable identifier
StrophantidinSeedSolvent extraction1.85 PercentNo resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Abubakirov, N. K. New cardiac glycosides from plants of Central Asia. Izuch. i ispol'z. lekarstv. rastit. resursov sssr (leningrad: med.), sb., 1964, p. 200-204.
  2. Khodzhaev, K. N., Shamsutdinov, M. I., Shakirov, T. T. Use of Erysimum diffusum seeds for obtaining strophanthidin acetate. Khimiya Prirodnykh Soedinenii, 1975, p. 245-246.
  3. Navruzova, A.M., Maslennikova, V.A., Abubakirov, N.K. Erysimum glycosides IX. Sinapoyl ester of erysimoside in Erysimum diffusum. Chemistry of Natural Compounds, 1975, vol. 9, no. 6, p. 718-722. DOI
  4. Maslennikova, V. A., Genkina, G. L., Umarova, R. U., Navruzova, A. M., Abubakirov, N. K. Glycosides of plants of Erysimum species. VI. Cardenolides of E. altacium, E. cuspidatum, E. diffusum, E. marschallianum, E. nuratensae, E. violascens, and Syrenia siliculosa. Khimiya Prirodnykh Soedinenii, 1967, p. 173-178.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue